Innate Pharma SA Interest Paid Classified As Financing Activities
Innate Pharma SA (IPHA) reported Interest Paid Classified As Financing Activities of EUR 0 for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Cash Flow › Financing Activities
ifrs-full:InterestPaidClassifiedAsFinancingActivities · last filed 2024-04-04
| Period end | Interest Paid Classified As Financing Activities 6 month | Interest Paid Classified As Financing Activities 12 month |
|---|---|---|
| 2023-12-31 | 0.00 EUR 20-F · filed 2024-04-04 | |
| 2023-06-30 | 0.00 EUR 6-K · filed 2023-09-14 | |
| 2022-12-31 | 0.00 EUR 20-F · filed 2024-04-04 | |
| 2022-06-30 | 194.00K EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | 312.00K EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | 160.00K EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | 341.00K EUR 20-F · filed 2023-04-06 | |
| 2020-06-30 | 173.00K EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 204.00K EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 102.00K EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 113.00K EUR 20-F · filed 2020-04-24 |